全文获取类型
收费全文 | 2834篇 |
免费 | 198篇 |
国内免费 | 117篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 98篇 |
妇产科学 | 69篇 |
基础医学 | 343篇 |
口腔科学 | 24篇 |
临床医学 | 331篇 |
内科学 | 533篇 |
皮肤病学 | 44篇 |
神经病学 | 226篇 |
特种医学 | 226篇 |
外科学 | 327篇 |
综合类 | 78篇 |
一般理论 | 1篇 |
预防医学 | 291篇 |
眼科学 | 104篇 |
药学 | 198篇 |
中国医学 | 9篇 |
肿瘤学 | 214篇 |
出版年
2023年 | 10篇 |
2022年 | 26篇 |
2021年 | 32篇 |
2020年 | 29篇 |
2019年 | 37篇 |
2018年 | 52篇 |
2017年 | 41篇 |
2016年 | 56篇 |
2015年 | 66篇 |
2014年 | 61篇 |
2013年 | 124篇 |
2012年 | 156篇 |
2011年 | 127篇 |
2010年 | 98篇 |
2009年 | 94篇 |
2008年 | 111篇 |
2007年 | 182篇 |
2006年 | 135篇 |
2005年 | 131篇 |
2004年 | 112篇 |
2003年 | 111篇 |
2002年 | 111篇 |
2001年 | 93篇 |
2000年 | 85篇 |
1999年 | 75篇 |
1998年 | 62篇 |
1997年 | 64篇 |
1996年 | 49篇 |
1995年 | 52篇 |
1994年 | 55篇 |
1993年 | 41篇 |
1992年 | 68篇 |
1991年 | 53篇 |
1990年 | 63篇 |
1989年 | 56篇 |
1988年 | 57篇 |
1987年 | 45篇 |
1986年 | 32篇 |
1985年 | 41篇 |
1984年 | 27篇 |
1983年 | 15篇 |
1982年 | 12篇 |
1981年 | 21篇 |
1980年 | 20篇 |
1979年 | 16篇 |
1976年 | 14篇 |
1975年 | 10篇 |
1974年 | 13篇 |
1969年 | 9篇 |
1958年 | 14篇 |
排序方式: 共有3149条查询结果,搜索用时 20 毫秒
91.
92.
Hurdman J Condliffe R Elliot CA Davies C Hill C Wild JM Capener D Sephton P Hamilton N Armstrong IJ Billings C Lawrie A Sabroe I Akil M O'Toole L Kiely DG 《The European respiratory journal》2012,39(4):945-955
Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists reflecting the spectrum of disease across the five diagnostic groups encountered in a specialist referral centre. Data was retrieved for consecutive, treatment-na?ve cases diagnosed between 2001 and 2010 using a catheter-based approach. 1,344 patients were enrolled, with a mean follow-up of 2.9 yrs. The 3-yr survival was 68% for pulmonary arterial hypertension (PAH), 73% for PH associated with left heart disease, 44% for PH associated with lung disease (PH-lung), 71% for chronic thromboembolic PH (CTEPH) and 59% for miscellaneous PH. Compared with PAH, survival was inferior in PH-lung and superior in CTEPH (p<0.05). Multivariate analysis demonstrated that diagnostic group independently predicted survival. Within PAH, Eisenmenger's survival was superior to idiopathic PAH, which was superior to PAH associated with systemic sclerosis (p<0.005). Within PH-lung, 3-yr survival in sleep disorders/alveolar hypoventilation (90%) was superior to PH-lung with chronic obstructive pulmonary disease (41%) and interstitial lung disease (16%) (p<0.05). In CTEPH, long-term survival was best in patients with surgically accessible disease undergoing pulmonary endarterectomy. In this large registry of consecutive, treatment-na?ve patients identified at a specialist PH centre, outcomes and characteristics differed between and within PH groups. The current system of classification of PH has prognostic value even when adjusted for age and disease severity, emphasising the importance of systematic evaluation and precise classification. 相似文献
93.
A. Zbinden A. Imhof M.J. Wilhelm F. Ruschitzka P. Wild G.V. Bloemberg N.J. Mueller 《Transplant infectious disease》2012,14(5):E60-E63
Opportunistic invasive fungal infections are a major cause of mortality in immunocompromised patients. Early diagnosis of invasive aspergillosis and proper identification of the causative agent is crucial for guidance of therapy. Accurate differentiation of Aspergillus lentulus, a filamentous fungus often misidentified as atypical Aspergillus fumigatus, is of concern as multiple antifungal drugs show a reduced susceptibility. This is the first report, to our knowledge, of a proven pulmonary invasive fungal infection caused by A. lentulus after heart transplantation. 相似文献
94.
95.
Verena Tenten Sylvia Menzel Uta Kunter Eva-Maria Sicking Claudia R. C. van Roeyen Silja K. Sanden Michaela Kaldenbach Peter Boor Astrid Fuss Sandra Uhlig Regina Lanzmich Brigith Willemsen Henry Dijkman Martin Grepl Klemens Wild Wilhelm Kriz Bart Smeets Jürgen Floege Marcus J. Moeller 《Journal of the American Society of Nephrology : JASN》2013,24(12):1966-1980
96.
Alexander Konnopka Claudia Kaufmann Hans-Helmut König Dirk Heider Beate Wild Joachim Szecsenyi Wolfgang Herzog Sven Heinrich Rainer Schaefert 《Journal of psychosomatic research》2013
Objective
To analyse the association of direct and indirect costs in patients with medically unexplained symptoms (MUS) with somatic symptom severity (SSS).Methods
A cross-sectional cost analysis for retrospective 6 months was conducted in 294 primary care patients with MUS. Health care utilisation and loss of productivity were measured by questionnaires. SSS was measured using the “Patient Health Questionnaire 15” (PHQ-15). Direct and indirect costs and the association of costs with SSS were analysed via multiple linear regression analysis.Results
Patients with MUS had average 6-month direct costs of 1098 EUR and indirect costs of 7645 EUR. For direct costs, outpatient physician visits were the most expensive single cost category (36%), followed by pharmaceuticals (25%) and hospital stays (19%). Indirect costs were predominantly caused by productivity reduction at work (56%) followed by early retirement (29%) and acute sickness absence (14%). As compared to mild SSS, moderate SSS was not significantly associated with direct, but with indirect costs (+ 2948 EUR; p < .001); severe SSS was associated with increased direct cost (+ 658 EUR; p = .001) and increased indirect costs (+ 4630 EUR; p < .001). Age was positively associated with direct cost (+ 15 EUR for each additional year; p = .015) as well as indirect cost (+ 104 EUR for each additional year; p < .001).Conclusions
MUS are associated with relevant direct and even much higher indirect costs that strongly depend on SSS. 相似文献97.
Teuber Ziwen Nussbeck Fridtjof W. Wild Elke 《Child psychiatry and human development》2022,53(2):403-403
Child Psychiatry & Human Development - A correction to this paper has been published: https://doi.org/10.1007/s10578-021-01198-3 相似文献
98.
99.
Ebele M. Umeukeje Joseph R. Merighi Teri Browne Marcus Wild Hafez Alsmaan Kausik Umanath Julia B. Lewis Kenneth A. Wallston Kerri L. Cavanaugh 《Journal of behavioral medicine》2016,39(6):1104-1114
This study was designed to assess dialysis subjects’ perceived autonomy support association with phosphate binder medication adherence, race and gender. A multi-site cross-sectional study was conducted among 377 dialysis subjects. The Health Care Climate (HCC) Questionnaire assessed subjects’ perception of their providers’ autonomy support for phosphate binder use, and adherence was assessed by the self-reported Morisky Medication Adherence Scale. Serum phosphorus was obtained from the medical record. Regression models were used to examine independent factors of medication adherence, serum phosphorus, and differences by race and gender. Non-white HCC scores were consistently lower compared with white subjects’ scores. No differences were observed by gender. Reported phosphate binder adherence was associated with HCC score, and also with phosphorus control. No significant association was found between HCC score and serum phosphorus. Autonomy support, especially in non-white end stage renal disease subjects, may be an appropriate target for culturally informed strategies to optimize mineral bone health. 相似文献
100.
Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 总被引:60,自引:0,他引:60
OBJECTIVE: The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030. RESEARCH DESIGN AND METHODS: Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030. Urban and rural populations were considered separately for developing countries. RESULTS: The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030. The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men. The urban population in developing countries is projected to double between 2000 and 2030. The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age. CONCLUSIONS: These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant. Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence. 相似文献